CNS Pharmaceuticals
CNSP • NASDAQ
CNS Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rami Levin, with a market cap of $1.5M.
CEORami Levin
Next Earnings
Upcoming earnings announcement for CNS Pharmaceuticals
Date
Friday, May 15, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$5.37
Earnings History
Past 11 earnings reports for CNS Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$5.76Est: -$6.63 | +13.1% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$6.42 | — | - | — | 10-Q |
| May 16, 2025 | Q4 2024 | -$1.58Est: -$6.00 | +73.7% | - | — | — |
| Nov 15, 2024 | Q3 2024 | -$12.50Est: -$5.00 | -150.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$336.00 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$1,025.00 | — | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$2,375.00 | — | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$2,700.00 | — | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$2,600.00 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$6,475.00 | — | - | — | — |
| Apr 3, 2023 | Q4 2022 | -$9,550.00 | — | - | — | — |